Robuta

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-lurbinectedin-and-atezolizumab-to-improve-treatment-for-small-cell-lung-cancer-imforte
This trial is looking at adding lurbinectedin to atezolizumab to help treat small cell lung cancer (SCLC).
triallurbinectedinatezolizumabimprovetreatment
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-tecentriq-atezolizumab-adjuvant-treatment-following-resection
Listen to a soundcast of the October 15, 2021 FDA approval of Tecentriq (atezolizumab) for adjuvant treatment following resection and platinum-based...
d is cfdaburstedition
https://www.ajmc.com/view/atezolizumab-treatment-safe-and-effective-in-metastatic-urothelial-cancer-patients
Patients with metastatic urothelial cancer treated with atezolizumab monotherapy demonstrated tolerability for the drug and general ability to manage adverse...
urothelial canceratezolizumabtreatmentsafeeffective
https://www.mayo.edu/research/clinical-trials/cls-20379679
Learn more about services at Mayo Clinic.
combination chemotherapywithoutatezolizumabtreatingpatients
https://www.mayo.edu/research/clinical-trials/cls-20438526
Learn more about services at Mayo Clinic.
in combinationolaparibatezolizumabeitheralone
https://www.academia.edu/143847770/Phase_I_Study_of_Entinostat_Atezolizumab_Carboplatin_and_Etoposide_in_Previously_Untreated_Extensive_Stage_Small_Cell_Lung_Cancer_ETCTN_10399
Background CREBBP and EP300 mutations occur at a frequency of 15% and 13%, respectively, in small cell lung cancer (SCLC), and preclinical models demonstrated...
phase i studypdfentinostatatezolizumabcarboplatin
https://www.mayo.edu/research/clinical-trials/cls-20391800
Learn more about services at Mayo Clinic.
open label studycisgem
https://www.ajmc.com/view/atezolizumab-bevacizumab-shown-effective-against-chc
The combination is approved to treat hepatocellular carcinoma (HCC), but this case report suggests it can also work for combined HCC and cholangiocarcinoma...
atezolizumabbevacizumabshowneffectivechc